1. Japan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
TOHO HOLDINGS CO., LTD.

TOHO HOLDINGS CO., LTD.

22.40
EUR
+0.20
(+0.90%)
Nov 11Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
15,954.55
15,611.16
19,020.88
17,925.74
17,699.61
18,312.45
18,169.47
17,165.25
17,952.38
20,089.05
22,885.93
23,966.57
24,311.26
- -
Basic EPS, GAAP
139.57
181.82
316.51
207.11
209.83
207.71
233.34
70.76
189.69
196.69
320.14
313.2
271.18
- -
Free Cash Flow per Basic Share
-349.86
336.67
-60.03
109.21
626.86
144.27
-43.92
43.17
172.11
-36.48
870.25
-511.88
152.28
- -
Dividend per Share
17.7
22.27
25.21
29.96
30.04
30.34
34.89
35
30
31.56
34.64
47.62
85.28
- -
Book Value per Share
1,952.38
2,247.02
2,545.52
2,738.39
3,033
3,137.87
3,276.18
3,366.87
3,417.57
3,625.95
3,971.46
4,101.7
4,195.12
- -
Tangible Book Value per Share
1,766.55
2,073.36
2,407.13
2,632.24
2,957.69
3,079.45
3,210.88
3,294.4
3,344.18
3,545.66
3,881.68
4,004.46
4,070.25
- -
Basic Weighted Avg Shares
75
74
69
69
69
67
70
71
71
69
65
63
64
64
Sales/Revenue/Turnover
1,189,624
1,162,114
1,308,358
1,231,175
1,213,322
1,222,195
1,263,769
1,210,334
1,266,171
1,392,117
1,476,712
1,518,495
1,553,364
- -
Operating Margin (%)
1.04
0.85
2.19
1.16
1.57
1.29
1.39
0.36
0.99
1.18
1.31
1.24
1.05
- -
Depreciation Expense
6,099
7,272
7,295
6,671
6,455
6,441
5,839
6,796
6,957
6,413
6,514
6,079
6,160
- -
Net Income, GAAP
10,407
13,535
21,771
14,225
14,384
13,863
16,230
4,989
13,379
13,630
20,657
19,844
17,327
- -
Effective Tax Rate (%)
41.88
37.01
38
34.95
37.99
33.71
33.06
51.43
33.29
33.15
32.85
29.22
33.67
- -
Profit Margin (%)
0.87
1.16
1.66
1.16
1.19
1.13
1.28
0.41
1.06
0.98
1.4
1.31
1.12
- -
Working Capital
25,130
39,855
53,314
58,294
66,897
79,162
99,958
110,194
110,288
93,331
126,583
124,938
129,124
- -
LT Debt
20,293
30,581
25,805
21,548
24,156
27,526
40,830
40,269
33,596
7,495
29,118
18,953
8,702
- -
Total Equity
147,188
157,368
174,656
188,270
207,770
213,846
231,007
237,402
241,278
242,915
249,434
256,895
271,557
- -
Return on Invested Capital (%)
4.1
3.25
8.38
4.22
5.12
4.21
4.39
0.74
2.93
3.82
4.53
4.69
3.85
- -
Return on Capital (%)
6.27
7.25
10.77
6.71
6.39
5.71
6.16
1.8
4.76
4.85
7.38
7.12
6.2
- -
Return on Common Equity (%)
7.4
8.89
13.11
7.84
7.26
6.58
7.3
2.13
5.59
5.63
8.39
7.84
6.56
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
1,670
1,188
- -
LT Borrowings
6,155
7,035
- -
LT Finance Leases
- -
1,667
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
65
65
65
Market Capitalization
- -
- -
- -

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
581,341
571,044
- -
Cash, Cash Equivalents & STI
96,450
94,361
- -
Accounts Receivable, Net
350,178
358,732
- -
Inventories
92,079
89,975
- -
Total Current Liabilities
460,684
441,920
- -
Payables & Accruals
- -
- -
- -
ST Debt
1,670
1,188
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.56%
2.74%
5.71%
Free Cash Flow
-264.88%
-486.21%
-130%
Net Income, GAAP
11.56%
41%
-12.68%
Sales/Revenue/Turnover
1.83%
5.15%
2.3%
Total Cash Common Dividend
14.55%
21.38%
80.61%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1,518,495
2026
- -
- -
- -
- -
1,553,364
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
313.2
2026
- -
- -
- -
- -
271.18
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
47.62
2026
- -
- -
- -
- -
85.28
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Hiromi Edahiro
Full Time Employees
7,675
Sector
Distribution services
Industry
Medical distributors
Address
Tokyo Midtown Yaesu, Yaesu Central Tower Tokyo TY Japan 104-0028
IPO Date
Dec 11, 2002
Website
tohohd.co.jp
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Toho Holdings Co., Ltd. engages primarily in pharmaceutical wholesaling and related healthcare services in Japan. The company operates through segments including Pharmaceutical Wholesale Business, which distributes prescription pharmaceuticals, over-the-counter drugs, reagents, testing equipment, medical devices, health foods, nursing foods, hygiene materials, sphygmomanometers, blood glucose meters, and dispensing equipment to hospitals, clinics, and pharmacies; Dispensing Pharmacy Business, managing insurance and health-support pharmacies with home medical care, dementia cafes, and advanced pharmaceutical management; Pharmaceutical Manufacturing and Sales Business, producing generic drugs and contract manufacturing injectable pharmaceuticals; and Other Peripheral Businesses, providing clinical trial support via site management organizations, IT solutions such as ENIFwin inventory systems, ENIFvoice electronic medication history tools, ENI-Pharmacy prescription-dispensing systems, LXMATE HeLios and SELENE appointment systems, logistics platforms for specialty drugs like gene therapies, and customer support including medical institution startups, management consulting, and personnel recruitment. Founded in 1948 and headquartered at Tokyo Midtown Yaesu, Yaesu Central Tower 9F, 2-2-1 Yaesu, Chuo-ku, Tokyo, Japan, Toho Holdings lists on the Tokyo Stock Exchange Prime Market (8129.T) and employs 7,609 consolidated staff as of March 31, 2025. Recent developments include a capital and business alliance with PHARUMO, Inc. in 2025, building on their August 2024 business tie-up to integrate PHARUMO's Every series inventory DX solutions and PHARUMO Cloud with Toho's systems for enhanced pharmacy services and community medical DX; a business alliance with WACON Co., Ltd. announced in September 2024; and ongoing specialization in segments like home visitation support and advanced logistics for regenerative medicines.